ABSTRACT
RESUMO

Terceiro-ventriculostomia endoscópica pode ter eficácia em longo prazo em pacientes pré-termos e de baixo peso
Introduction
Endoscopic third ventriculostomy (ETV) is an established treatment for hydrocephalus and consists in communicating third ventricle with interpeduncular and pre pontine cistern.
1 ETV alone or associated in some patients with choroid plexus cauterization represents an alternative method to manage hydrocephalus avoiding shunts and its complications, and is a very useful technique to manage hydrocephalus specially in cases of aqueductal stenosis, arachnoid cysts, Chiari II malformation, ventricular and subarachnoid hemorrhage, ventriculitis as a consequence of meningitis, neurocysticercosis, and brain tumors causing hydrocephalus, such as midbrain, pineal, tectal plate, third ventricle, thalamic and posterior fossa tumors.
1,2 It may also be employed instead of shunt revision. 3, 4 Although endoscopic third ventriculostomy (ETV) is a procedure for the treatment of congenital and acquired hydrocephalus, there is still controversy regarding the higher risk of failure in younger infants compared to older children, especially below 2 years old. 5, 6 There is few experience concerning the success of ETV in low birth weight and preterm newborns and its long term functionality. 7, 8 Consequently, we illustrate such a case and review the pertinent current literature.
Case description
NARF was born in July 2005. He was the first son of a 31-year-old mother with 32 weeks of gestation. His mother performed prenatal visit at a tertiary hospital, with 4 consultations. Mother sorology was positive for rubella (immunized) and other blood tests were normal. The morphological ultrassonography of second quarter revealed changes of cephalic segment suggestive of nonspecific syndromic disease. After prolonged labor, NARF was born with 1,800 grams and cephalic perimeter of 31 cm. Shortly after birth, had tachycardia (HR > 100 bpm) and respiratory distress hypoactivity, requiring mask ventilation. Detailed neonatal examination showed Pierre Robin sequence, bilateral paralysis of sixth and seventh cranial nerves and stenosis of the larynx causing stridor and short neck. Further evaluation showed hydrocephalus with bilateral ventricular index of 0.6 ( Figure 1 ). Parents had no genetic diseases and were not consaguineous. NARF karyotype was 46 XY with 22ps+ polymorphism, which corresponds to an enlarged satellite of short arm of chromosome 22. Moebius Syndrome was then disclosed. Due to stenosis of larynx, an early tracheostomy was performed and neurosurgical evaluation was required because of a severe supratentorial hydrocephalus with cerebral aqueduct stenosis. It was then decided, in spite of prematurity and low birth weight to perform ETV with the age of 25 days, with 1,850 grams.
Surgery was uneventful and child developed with marked cognitive impairment, with limited language and motor skills, being bedridden and dependent to progenitor, remaining with permanent tracheostomy and recurrent pneumonia.
After discharge, follow-up was lost due to family moving to another city. By chance, after seven years, in the course of new severe pneumonia, child returned to our medical facility and a follow-up magnetic resonance revealed pervious ETV with high flow, surprisingly demonstrating functionality of ventriculostomy ( Figure 2 ).
Discussion
ETV can be considered an alternative to ventricular shunt for the treatment of occlusive hydrocephalus in infants. 8 However, patient's age and etiology of hydrocephalus are the most important factors influencing the success rate of ETV. [9] [10] [11] [12] [13] Some previous studies reported the success of ETV in children younger than 2 years old, and the prognosis seemed to be more linked to the etiology of hydrocephalus than the age of surgery. 6, 11 More recently, the age between 6 months to 1 year old seemed to be a cutoff, below which failure rates are reported to be particularly high and there are dichotomized experience and results. 9, [13] [14] [15] Other reports reinforce that there is a clear impact of age on ETV failure rate even excluding etiological factors, with the probability of ETV success gradually increasing during the first months of life, with a median age of 120 days. 10 At last, ETV may be effective in fullterm infants while the results in low birth weight and preterm infants may be poor. 
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Our experience with 14 children below 1 year old (mean age of 5 months) submitted to ETV by several causes revealed a success rate of 64%. From those, three children were below 1 month (mean age of 19 days old) and two of them have successfully proceeded (nonpublished).
The case presented above highlights the possible applicability of ETV to a case with both preterm and low birth weight features and a satisfactory long term result, reinforcing the security and efficacy of ETV even in newborns. Although the current MRI of NARF is still compatible with hydrocephalus, the functioning ETV ensures the reliability of the procedure, even in a long term basis. Besides, some studies state that functionality of the ventriculostomy and neurocognitive outcome are not always correlated with smaller sized ventricles after ETV. 16, 17 We agree that age does not present a contraindication for ETV, nor does increase the perioperative risk. 5 Nevertheless, our own experience is somehow limited and further studies are expected to bring new light into the question.
Although still questionable, the use of ETV appears to be a valid, safe and reliable option for the treatment of hydrocephalus even in preterm and low birth weight newborns.
